| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/23/2010 | US7666868 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 02/23/2010 | US7666863 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases |
| 02/23/2010 | CA2462289C Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 02/23/2010 | CA2345146C Cyanophenyl derivative |
| 02/18/2010 | WO2010019930A1 Urea derivatives as inhibitors of map kinases |
| 02/18/2010 | WO2010019772A2 Oxadiazole-2-oxides as antischistosomal agents |
| 02/18/2010 | WO2010019606A1 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators |
| 02/18/2010 | WO2010019101A1 A crystalline form of 4- (5-{ (ir) -1- [5- (3- chlorophenyl) isoxazol-3-yl] ethoxy } - 4 -methyl- 4h- 1, 2,4- triazol-3-yl) pyridine |
| 02/18/2010 | WO2010019100A1 A new crystalline form of 4- (5- { (ir) -1- [5- (3- chlorophenyl) isoxazol-3-yl] ethoxy } -4-methyl-4h-l, 2, 4- triazol-3-yl) pyridine |
| 02/18/2010 | WO2010018686A1 Nitrogenated heterocyclic derivative, and agricultural or horticultural bactericidal agent |
| 02/18/2010 | WO2010018328A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 02/18/2010 | WO2010018198A1 Polymerizable benzoxazine compositions |
| 02/18/2010 | US20100041886 Isoxazolo-pyrazine derivatives |
| 02/18/2010 | US20100041721 Selective androgen receptor modulators |
| 02/18/2010 | US20100041708 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for it's preparation |
| 02/18/2010 | US20100041706 Compounds 501 |
| 02/18/2010 | US20100041656 Novel amide derivatives and medicinal use thereof |
| 02/18/2010 | US20100041655 Triazole derivative |
| 02/18/2010 | US20100041654 Pyrimidine Derivatives And Their Use As CB2 Modulators |
| 02/18/2010 | US20100041653 Composition and methods for the design and development of metallo-enzyme inhibitors |
| 02/18/2010 | US20100041649 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth |
| 02/18/2010 | US20100041647 3-Substituted-[1,2,3]-Benzotriazinone compounds for enhancing glutamatergic synaptic responses |
| 02/18/2010 | US20100041646 Phenylene-Bis-Oxazolidine Derivatives and Their Use as Anticoagulants |
| 02/18/2010 | US20100041645 Rho kinase inhibitors |
| 02/18/2010 | US20100041642 Urea inhibitors of map kinases |
| 02/18/2010 | US20100041638 Chemical Compounds 293 |
| 02/18/2010 | US20100041637 1,3-Oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11ß-hydroxysteroid dehydrogenase 1 |
| 02/18/2010 | US20100041635 Oxindole compounds |
| 02/18/2010 | US20100041628 Novel indole derivative having ikappab kinase beta inhibitory activity |
| 02/18/2010 | US20100041555 3-Phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same |
| 02/18/2010 | US20100040753 Flavor molecules |
| 02/18/2010 | CA2733966A1 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators |
| 02/18/2010 | CA2733922A1 A crystalline form of 4-(5-{(1r)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4h-1,2,4-triazol-3-yl)pyridine |
| 02/18/2010 | CA2733920A1 A new crystalline form of 4-(5-{(1r)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4h-1,2,4-triazol-3-yl)pyridine |
| 02/18/2010 | CA2733397A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 02/18/2010 | CA2733190A1 Oxadiazole-2-oxides as antischistosomal agents |
| 02/17/2010 | EP2154138A1 Novel compounds for treatment of psychotic disorders, preparation methods and uses thereof |
| 02/17/2010 | EP2154130A1 Pyridone compound |
| 02/17/2010 | EP2153832A2 Heterocyclic aspartyl protease inhibitors |
| 02/17/2010 | EP2152701A1 Phenyl amino pyrimidine compounds and uses thereof |
| 02/17/2010 | EP2152700A1 Csf-1r inhibitors, compositions, and methods of use |
| 02/17/2010 | EP2152690A1 Pyridyl piperidine orexin receptor antagonists |
| 02/17/2010 | EP2152674A1 Benzimidazolone chymase inhibitors |
| 02/17/2010 | EP2152664A1 Dipeptide analogs as coagulation factor inhibitors |
| 02/17/2010 | EP2152370A1 Aryl ether pyridazinone derivatives |
| 02/17/2010 | EP2152082A1 Tetracyclic inhibitors of fatty acid amide hydrolase |
| 02/17/2010 | EP2152079A1 Heterocyclic compounds and uses thereof |
| 02/17/2010 | EP1902026B1 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
| 02/17/2010 | CN101652361A 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhbitors |
| 02/17/2010 | CN101648947A 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 02/17/2010 | CN101648944A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 02/16/2010 | US7663001 Preparation of isoxazolin-3-ylacylbenzene |
| 02/16/2010 | US7662977 Such as 2-cationic amino-4-oxo-chromene derivatives; water solubility, pharmacokinetics; reduced side effects; anticancer agents |
| 02/16/2010 | US7662972 Insecticidal and acaricidal activity for many agricultural insect pests, spider mites; endo- or ecto-parasiticide for mammals or birds; veterinary medicine; environmentally friendly |
| 02/16/2010 | US7662971 enzyme inhibitor for treating sleep disorders |
| 02/16/2010 | US7662847 Myelodysplastic syndrome, Parkinson*s disease, multiple sclerosis, AIDS, chronic obstructive pulmonary disease, acquired respiratory distress; analgesics, angiogenesis inhibitors; anticarcinogenic and antitumor agents; phopshodiesterase, tumor necrosis factor and matrix metalloproteinase inhibitors |
| 02/16/2010 | US7662839 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders; e.g. {4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl}-acetic acid |
| 02/16/2010 | US7662825 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/16/2010 | US7662818 e.g. 4-[5-(piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; and multiple sclerosis |
| 02/16/2010 | US7662816 Cognition activators; neurodegenerative disorders; Alzheimer's disease |
| 02/16/2010 | US7662814 4-(4-Ethylpiperazin-1-yl)-5-methyl-2-phenylthieno[2,3-d]pyrimidine-6-carbonitrile; asthma, atopic dermatitis, chronic obstructive pulmonary disease, Crohn's disease, type I and type II diabetes, lymphoid leukemia and other forms of cancer, multiple sclerosis and autoimmune diseases |
| 02/16/2010 | US7662813 Triazole compounds that modulate HSP90 activity |
| 02/16/2010 | US7662811 1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use |
| 02/16/2010 | US7662771 Drug delivery; controlled/sustained release |
| 02/16/2010 | CA2571627C Substituted aryl-amine derivatives and methods of use |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2450922C Piperidines for use as orexin receptor antagonists |
| 02/16/2010 | CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 02/16/2010 | CA2385938C Cyclic amine compounds as ccr5 antagonists |
| 02/11/2010 | WO2010017479A1 Triazole compounds that modulate hsp90 activity |
| 02/11/2010 | WO2010017401A1 Bi-1h-benzimidazoles as hepatitis c virus inhibitors |
| 02/11/2010 | WO2010017120A1 Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
| 02/11/2010 | WO2010017079A1 Oxazole derivatives useful as inhibitors of faah |
| 02/11/2010 | WO2010016554A1 Cyclic amine compound |
| 02/11/2010 | WO2010016549A1 Tricyclic compound |
| 02/11/2010 | WO2010015985A1 Tricyclic alkylaminomethyloxazolidinone derivatives |
| 02/11/2010 | WO2010015792A1 Nitrogen containing heterocyclic compounds useful as bifunctional modulators of m3 receptors and beta-2 receptors |
| 02/11/2010 | WO2010015613A1 Organic compounds |
| 02/11/2010 | WO2010015090A1 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 02/11/2010 | WO2009154754A3 Synthesis of deuterated morpholine derivatives |
| 02/11/2010 | WO2009139576A3 Pyridine derivatives substituted with novel benzoxazoles or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical compositions containing the same as active ingredients for prevention and treatment of abnormal cell growth disease |
| 02/11/2010 | WO2008142550A9 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors |
| 02/11/2010 | WO2008026216A3 Process for purification of aprepitant |
| 02/11/2010 | US20100036118 Fused Ring Heterocycle Kinase Modulators |
| 02/11/2010 | US20100035943 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 02/11/2010 | US20100035929 Unnatural dispyrin analogues, preparation and uses thereof |
| 02/11/2010 | US20100035880 Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as vr1 receptor antagonists |
| 02/11/2010 | US20100035879 N-sulfonylcarboximidamide apoptosis promoters |
| 02/11/2010 | US20100035874 Organic compounds |
| 02/11/2010 | US20100034827 Novel hiv reverse transcriptase inhibitors |
| 02/11/2010 | US20100034813 Substituted pyrazole and triazole compounds as ksp inhibitors |
| 02/11/2010 | CA2732932A1 Organic compounds |
| 02/11/2010 | CA2732526A1 Oxazole derivatives useful as inhibitors of faah |
| 02/11/2010 | CA2731365A1 Tricyclic alkylaminomethyloxazolidinone derivatives |
| 02/10/2010 | EP2151440A1 Heterocyclic compound and use thereof |
| 02/10/2010 | EP2150551A1 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors |
| 02/10/2010 | EP2150543A2 Heterocyclic compounds with affinity to muscarinic receptors |
| 02/10/2010 | EP2150539A1 Pyridazinone derivatives |
| 02/10/2010 | EP2150115A1 Cyclopropyl pyrrolidine orexin receptor antagonists |
| 02/10/2010 | EP1833805B1 New 3-phenylpropionic acid derivatives for the treatment of diabetes |